Bromide

Bromide

SCHEMBL3791302

C=CCn1cc[n+](CCCC)c1.[Br-]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
HSP90AA1 P07900 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
APAF1 O14727 1/20 0.37
NPC1 O15118 1/20 0.37
PLA2G1B P04054 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
ATG4B Q9Y4P1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1931517 0.98 MEN1 (0.38) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Water SCHEMBL15361621 0.97 MEN1 (0.37) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL5305079 0.97 MEN1 (0.37) MEN1HSP90AA1KMT2ASMN1; SMN2MAPT
Iodide SCHEMBL15361406 0.97 SMN1; SMN2 (0.37) MEN1HSP90AA1KMT2ASMN1; SMN2NPC1
Bromide SCHEMBL4364809 0.95 MEN1 (0.42) MEN1HSP90AA1KMT2ASMN1; SMN2
Bromide SCHEMBL29770293 0.94 HSP90AA1 (0.44) MEN1HSP90AA1KMT2ASMN1; SMN2PLA2G1B
Bromide SCHEMBL4362535 0.94 HSP90AA1 (0.44) MEN1HSP90AA1KMT2ASMN1; SMN2PLA2G1B
SCHEMBL1680333 0.93 MEN1 (0.40) MEN1HSP90AA1KMT2ASMN1; SMN2
Boric Acid SCHEMBL28678124 0.92 MEN1 (0.38) MEN1HSP90AA1KMT2ASMN1; SMN2
SCHEMBL4356689 0.92 MEN1 (0.35) MEN1HSP90AA1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852532-A Ionic liquid grafted modified starch filtrate reducer and preparation method and application thereof 中国石油天然气集团有限公司 2024-10-29 CN claimed
CN-111435705-B Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2023-04-07 CN claimed
CN-115732749-A Composite solid electrolyte and preparation method thereof 多氟多新材料股份有限公司 2023-03-03 CN claimed
CN-111205397-B Ionic liquid grafted cellulose nanocrystal and preparation method thereof 青岛科技大学 2022-08-23 CN claimed
CN-114570219-A Pollution-resistant separation membrane with ionic liquid layer on surface and preparation method thereof 浙江大学 2022-06-03 CN claimed
CN-113025304-A Electrochromic material and preparation method and application thereof 中科院过程工程研究所南京绿色制造产业创新研究院 2021-06-25 CN claimed
CN-109749730-B Efficient and environment-friendly slickwater fracturing fluid drag reducer and preparation method thereof 大庆玮德化工有限公司 2021-05-07 CN claimed
CN-112086564-A Passivating agent and passivation method thereof and method for preparing semiconductor film 杭州纤纳光电科技有限公司 2020-12-15 CN claimed
CN-111435705-A Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2020-07-21 CN claimed
CN-111205397-A Ionic liquid grafted cellulose nanocrystal and preparation method thereof 青岛科技大学 2020-05-29 CN claimed
US-12540199-B2 Molding material production method and molding material SEIKO EPSON CORPORATION (JP) 2026-02-03 US disclosed
US-20240317896-A1 Molding Material Production Method And Molding Material SEIKO EPSON CORPORATION (JP) 2024-09-26 US disclosed
CN-118684785-A Method for producing molding material and molding material 精工爱普生株式会社 2024-09-24 CN disclosed
CN-114437288-B Filtrate reducer for drilling fluid and preparation method and application thereof 中国石油化工股份有限公司 2023-04-11 CN disclosed
CN-111435705-B Repairing agent and repairing method thereof and method for preparing photoelectric film 杭州纤纳光电科技有限公司 2023-04-07 CN disclosed
EP-2495803-A1 LITHIUM-AIR BATTERY Sony Corporation (JP) 2012-09-05 EP disclosed
US-20100261945-A1 METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND SAMSUNG ENGINEERING CO., LTD. (KR) 2010-10-14 US disclosed
US-7517999-B2 needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide KANTO KAGAKU KABUSHIKI KAISHA (JP) 2009-04-14 US disclosed
US-20070191612-A1 Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide HIROYUKI OHNO (JP) 2007-08-16 US disclosed
EP-1721900-A1 NOVEL IMIDAZOLIUM COMPOUND Kanto Kagaku Kabushiki Kaisha (JP) 2006-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191612-A1 Needs no complicated operations for dissolution and has excellent handleability and a high ionic conductivity, electrolytes; 1-butyl-3-allylimidazolium bromide SLC26A3, KCNJ11, SLC26A4 MEN1 636/4885HSP90AA1 3528/4885KMT2A 4733/4885
US-12540199-B2 Molding material production method and molding material ACP1, RPL28, PLIN3 MEN1 471/4885HSP90AA1 278/4885KMT2A 996/4885
US-20100261945-A1 METHOD OF SEPARATING AROMATIC COMPOUND FROM MIXTURE CONTAINING AROMATIC COMPOUND AND ALIPHATIC COMPOUND AHR, ALK, PAH MEN1 1736/4885HSP90AA1 4671/4885KMT2A 574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.